WHO sets dates for reviews of Sinopharm and Sinovac Covid-19 vaccines
"We would expect a decision a couple of days later," the WHO said
File Photo: A logo is pictured on the headquarters of the World Health Orgnaization (WHO) in Geneva, Switzerland, June 25, 2020. Photo: Reuters/Denis Balibouse
Technical experts at the World Health Organization (WHO) will review on April 26 Chinese drugmaker Sinopharm's Covid-19 vaccine for possible emergency use listing, to be followed by the Sinovac jab on May 3, the agency said on Thursday.
"We would expect a decision a couple of days later," the WHO said in response to a Reuters query.
So far Covid-19 vaccines made by Pfizer AstraZeneca and Johnson & Johnson have received a WHO listing - an endorsement of their safety and efficacy that helps to guide countries' regulatory agencies.
Keep updated, follow The Business Standard's Google news channel
